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hydrochloric acid to form the rare-earth chloride compounds, respectively. Then, the rare earth chloride compounds were dried by solvent evaporation, and redispersed in water to yield the YCl 3 (1.6 mol L -1 ), YbCl 3 (0.6 mol L -1 ), NdCl 3 (0.6 mol L -1 ) and ErCl 3 (0.1 mol L -1 ) aqueous stocking solutions, respectively. 1-octadecene (1-ODE, ≥90%), oleic acid (OA, ≥90%), Triton X-100 and tetraethyl orthosilicate (TEOS, 
Synthesis of UCND@SiO 2 -COOH
S3
To synthesis UCND@SiO 2 -COOH, 7.5 mL cyclohexane containing UCNDs (6 mg mL -1 ), 1.8 mL TritonX-100, 1.8 mL n-hexanol, and 0.48 mL H 2 O were mixed and stirred for 30 min.
Then 90 µL NH 4 OH (28 wt%) and 120 µL TEOS were added into the mixture. After stirring for 5.75 h, 140 µL CTES was added and kept stirring at room temperature for 24 h. The final product was precipitated by addition of 5 mL acetone, collected by centrifugation (10,000 rpm), and washed with ethanol for three times. Finally, the UCND@SiO 2 -COOH was dispersed in water.
Cytotoxicity Study of UCND@SiO 2 -COOH
The HeLa cells were cultured in fresh DMEM medium supplemented with 10% fetal bovine serum (FBS) and 100 U mL -1 penicillin-streptomycin under a humidified 5% CO 2 at 37 °C. To evaluate the cytotoxicity of UCND@SiO 2 -COOH, the HeLa cells were cultured in 96-well cell-culturing plate (1 × 10 4 cells per well in 100 µL culture medium) for 24 h. After removed the culture medium and washed with PBS for three times, 100 µL fresh culture medium containing the UCND@SiO 2 -COOH with desired concentrations (6.25, 12.5, 25, 50, 100 and 200 µg mL −1 ) were introduced into the wells and incubated for another 24 h, respectively. The cell viabilities were determined by traditional 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 1, 2 .
UCL Imaging of Cells
For UCL imaging, HeLa cells (5 × 10 4 cells per well in 0.5 mL culture medium) were seeded in a 48-well culturing plate for 24 h. After discharged the culture medium and washed with PBS for three times, 0.5 mL fresh culture medium containing UCND@SiO 2 -COOH with varying concentrations (25, 50, 100 and 200 µg mL -1 ) were added into the corresponding wells and incubated for 24 h. After washed with PBS (3 times), the NP-stained cells were fixed with 4% paraformaldehyde for 20 min and subjected to UCL imaging under an external 980 nm laser (0.5 W cm -2 ).
Besides, fresh culture medium containing 100 µg mL -1 UCND@SiO 2 -COOH were added to the wells and incubated at the same conditions for different time (0.5, 1, 2, 4, S4 6, 8, 12 and 24 h), respectively.
In vivo UCL Imaging of UCND@SiO 2 -COOH.
200 µL 0.9 wt% NaCl solutions containing UCND@SiO 2 -COOH (1.5 mg mL −1 ) were intravenously injected into a healthy Balb/c mouse. Then the UCL images of livers were recorded at the appropriate time points (0, 0.5, 1, 2, 4, 6, 8, 10, 12 and 24 h postinjection) under the excitation of 980 nm NIR laser (1.5 W cm -2 ), respectively. In addition, the mouse injected with 200 µL 0.9 wt% NaCl solutions containing UCND@SiO 2 -COOH (1.5 mg mL −1 ) was sacrificed at 8 h post-injection, and the organs (heart, liver, spleen, lung, and kidneys) were collected for ex vivo UCL imaging.
All of the UCL images were recorded by M2590 (Genie TM Nano Cameras) with a 700 nm short pass filter (SP700, FWHM 150 nm).
In Vivo Toxicology Analysis of UCND@SiO 2 -COOH.
6 healthy Balb/c mice were randomly divided into two groups, which were received intravenous injections of 200 µL 0.9 wt% NaCl solution only (control group), 200 µL 0.9 wt% NaCl solution containing UCND@SiO 2 -COOH at a dose of 10 mg kg -1 through tail veins, respectively. The body weight of each mouse was monitored every five days. After 30 days, blood samples and organs (heart, liver, spleen, lung, and kidneys) were harvested from both the control and the experiment mice. The organs were fixed in 4% (w/v) paraformaldehyde solution, embedded in paraffin, sectioned, and finally stained with hematoxylin-eosin (H&E) for histological examinations. The blood samples were analyzed by the blood biochemistry assay. Table S5 . Results of hematology analysis and blood biochemical assays.
